| ATRA | All-trans retinoic acid |
| CER | Ceramide |
| CERS | Ceramide synthase |
| GG | Ganglioside |
| GSL | Glycosphingolipid |
| HR | High-risk |
| LR | Low-risk |
| MHC-1 | Major histocompatibility complex I |
| NBL | Neuroblastoma |
| NK | Natural killer cell |
| TrkA | Tyrosin kinase receptor A |
| ATRA | All-trans retinoic acid |
| CER | Ceramide |
| CERS | Ceramide synthase |
| GG | Ganglioside |
| GSL | Glycosphingolipid |
| HR | High-risk |
| LR | Low-risk |
| MHC-1 | Major histocompatibility complex I |
| NBL | Neuroblastoma |
| NK | Natural killer cell |
| TrkA | Tyrosin kinase receptor A |